EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
What is the latest Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹35.96 |
| Mar2025 | ₹27.50 |
| Mar2024 | ₹29.42 |
| Mar2023 | ₹36.62 |
| Mar2022 | ₹21.68 |
How is Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹35.96 | 30.76 | |
| Mar2025 | ₹27.50 | -6.53 | |
| Mar2024 | ₹29.42 | -19.66 | |
| Mar2023 | ₹36.62 | 68.91 | |
| Mar2022 | ₹21.68 | - | |
Compare Earnings Per Share (EPS) of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,776.2 Cr | 0.7% | 4.4% | 51.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.7% |
4.4% |
51.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses